TUMORI JOURNAL, vol.89, no.4, pp.405-407, 2003 (Journal Indexed in SCI)
Article / Article
Title of Journal :
gastric cancer, irinotecan, second-line chemotherapy, SUPPORTIVE CARE, PHASE-II, METHOTREXATE, CARBOPLATIN, PACLITAXEL, CISPLATIN
Aim: To investigate the activity and toxicity of irinotecan (CPT-11) as a single agent in patients with advanced gastric cancer after failure of previous 5-fluorouracil-based combination chemotherapy.